Biomarker weist frühzeitig auf schwere COVID-19-Verläufe hin
Covid19-Sources
Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
Is Omicron Reinfection Possible? Here’s What Experts Want You to Know
Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
%2Fcloudfront-eu-central-1.images.arcpublishing.com%2Fmadsack%2FRPMY3GV23NEKBGKWPAGWBZGUQQ.jpg?width=92&height=&ar=&mode=&format=avif&dpr=2)
Long-Covid-Expertin warnt: „Mehrere Hunderttausend bis Millionen Menschen werden Spätfolgen haben“
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae
Eric Topol on Twitter
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections - 2022.01.10.475725v1.full.pdf
Anthony J Leonardi, PhD, MS on Twitter
Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline
The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment - 2022.01.08.22268944v1.full.pdf
Covid loses 90% of ability to infect within five minutes in air – study
Effectiveness of BNT162b2 (Pfizer-BioNTech) ...
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California
desh-data/README.md at main · corneliusroemer/desh-data
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report - PMC
Studie: COVID-19 könnte Diabetes bei Kindern begünstigen
(1) Denise Dewald, MD 🗽 auf Twitter: "Again, when they tell you that the long-term devastation of Long Covid could not have been foreseen, do not believe them. SARS1 devastated the long-term health of a substantial proportion of survivors. It's a neuroinvasive virus that can damage the brain. https://t.co/lTP6DziBFf https://t.co/TwgH45RfAl" / Twitter
Early Data Hints at Omicron’s Potential Toll Across America
Active epidemiological investigation on SARS-CoV-2 infection caused by Omicron variant (Pango lineage B.1.1.529) in Japan: preliminary report on infectious period
RKI Vitamin D Deutschland
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study